Source: Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?



Rating:

Share or cite this content

Citations should be made in the following way:
I. Lang (Vienna, Austria). The biggest challenge we face in PAH today is … To treat more aggressively. Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?

Member's Comments

- 01.11.2011 14:42
BRAIN CHALLEMGING PRESENTATION

Related content which might interest you: The biggest challenge we face in PAH today is … To diagnose patients sooner Source: Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome? Year: 2011 The biggest challenge we face in PAH today is … To recognise deterioration sooner Source: Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome? Year: 2011 Managing difficult to treat P-NTM: boredom or challenge Source: International Congress 2017 – GR4 Clinical Grand Round: always the same, really? Year: 2017 Two major problems in TB patients today: MDR and the abandoned therapy Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011 How quickly do we identify and treat patients with TB ? Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 How are we going to treat IPF patients in the future? Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges Year: 2013 A new cause of difficult to treat asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Which are the best methods to manage COPD patients in the post-COVID era? Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era Year: 2021 Preventing skin care issues associated with face masks used for domiciliary non-invasive ventilation: what do users and their carers think are the most relevant future research questions? Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation Year: 2019 Treating asthma in developing countries: is this a question of money? Source: Eur Respir J 2005; 26: Suppl. 49, 274s Year: 2005 What the pulmonary specialist should know about the new inhalation therapies Source: Guideline 2011 Year: 2011 What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2012; 39: 1055-1056 Year: 2012 What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2012; 39: 1054-1055 Year: 2012 Will clinicians keep their place in modern management of tuberculosis? Source: Eur Respir J 2001; 18: Suppl. 33, 474s Year: 2001 The face of COPD in Scotland now and in the future is increasingly female and poor Source: Eur Respir J 2004; 24: Suppl. 48, 359s Year: 2004 Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations? Source: Eur Respir J 2005; 26: Suppl. 49, 310s Year: 2005 Should we treat every patient with latent TB? Is there a cost to pay? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Recognising advanced disease, advance care planning and recognition of dying for people with COPD Source: Eur Respir Monogr 2016; 73: 204-220 Year: 2016 How to treat children's pneumonia: a complex problem Source: Eur Respir J 2010; 35: 932-933 Year: 2010